Sanford Biotech biological therapies

 

A modern approach to tissue regeneration

Sanford Biotech develops innovative biological therapies based on the body's natural repair mechanisms. Our solutions combine science and clinical practice, offering effective treatments for animals with degenerative, inflammatory and post-traumatic conditions.

 

Key technologies:

  • MSC – Mesenchymal stem cells support the regeneration of cartilage, bone and soft tissues, acting as anti-inflammatory and immunomodulatory agents.

  • PRP – platelet-rich plasma – a platelet concentrate that accelerates healing and tissue regeneration. Used in orthopaedics, dermatology and veterinary sports medicine.

  • ILA-1 – interleukin therapy – a modern biological therapy that inhibits the interleukin-1 (IL-1) pathway, responsible for chronic inflammation in joints and tissues.

See the Publications section for details of our work in the field of regenerative medicine.